journal article·2023-10

Single-component nanoagents with large Stokes shift for high-effect phototheranostics

Qin Zhang, Xinmin Zhang, Mingxuan Fu, Yanwei Xiong, Tangxin Xiao, Qi Wang

Dyes and Pigments· Volume 218
Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Photoacoustic and Ultrasonic Imaging · Photodynamic Therapy Research Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (44)

Show source-provided references
1. Polyprodrug nanomedicines: an emerging paradigm for cancer therapy
2. Design of superior phototheranostic agents guided by Jablonski diagrams10.1039/D0CS00671H ↗
3. Biogenic cluster-encased gold nanorods as a targeted three-in-one theranostic nanoenvelope for SERS-guided photochemotherapy against metastatic melanoma10.1021/acsabm.8b00746 ↗
4. GOx-assisted synthesis of pillar[5]arene based supramolecular polymeric nanoparticles for targeted/synergistic chemo-chemodynamic cancer therapy10.1186/s12951-021-01237-0 ↗
5. Triphenylamine flanked boron difluoride formazanate for NIR-II fluorescence imaging-guided photothermal therapy10.1016/j.dyepig.2022.110478 ↗
6. Recent development of pH-responsive theranostic nanoplatforms for magnetic resonance imaging-guided cancer therapy10.1002/EXP.20220002 ↗
7. Boosting fluorescence-photoacoustic-Raman properties in one fluorophore for precise cancer surgery10.1016/j.chempr.2019.07.015 ↗
8. Recent advances in dual- and multi-responsive nanomedicines for precision cancer therapy10.1016/j.biomaterials.2022.121906 ↗
9. A small-molecule based organic nanoparticle for photothermal therapy and near-infrared-IIb imaging10.1021/acsami.2c11706 ↗
10. Semiconducting polymer nanoparticles with intramolecular motion-induced photothermy for tumor phototheranostics and tooth root canal therapy10.1002/adma.202200179 ↗
11. Metabolizable photosensitizer with aggregation-induced emission for photodynamic therapy10.1021/acs.chemmater.1c01173 ↗
12. Albumin-based therapeutics capable of glutathione consumption and hydrogen peroxide generation for synergetic chemodynamic and chemotherapy of cancer10.1021/acsnano.1c08536 ↗
13. Icing on the cake: combining a dual PEG-functionalized pillararene and an A-D-A small molecule photosensitizer for multimodal phototherapy10.1007/s11426-022-1232-9 ↗
14. A nanoplatform for mild-temperature photothermal and type I & II photodynamic therapy in the NIR-II biowindow10.1039/D2CC03248A ↗
15. Light triggered release of a triple action porphyrin-cisplatin conjugate evokes stronger immunogenic cell death for chemotherapy, photodynamic therapy and cancer immunotherapy10.1186/s12951-022-01531-5 ↗
16. Diketopyrrolopyrrole derivatives-based NIR-II fluorophores for theranostics10.1016/j.dyepig.2021.109480 ↗
17. Crucial breakthrough of second near-infrared biological window fluorophores: design and synthesis toward multimodal imaging and theranostics10.1039/C8CS00234G ↗
18. An oral ratiometric NIR-II fluorescent probe for reliable monitoring of gastrointestinal diseases in vivo10.1016/j.biomaterials.2022.121956 ↗
19. Versatile types of inorganic/organic NIR-IIa/IIb fluorophores: from strategic design toward molecular imaging and theranostics10.1021/acs.chemrev.1c00553 ↗
20. Molecular programming of NIR-IIb-emissive semiconducting small molecules for in vivo high-contrast bioimaging beyond 1500 nm10.1002/adma.202201263 ↗
21. Near-infrared luminescence high-contrast in vivo biomedical imaging10.1038/s44222-022-00002-8 ↗
22. A “dual-source, dual-activation” strategy for an NIR-II window theranostic nanosystem enabling optimal photothermal-ion combination therapy10.1002/smll.202201179 ↗
23. Rational design of high brightness NIR-II organic dyes with S-D-A-D-S structure10.1021/accountsmr.0c00114 ↗
24. Design of one-for-all near-infrared aggregation-induced emission nanoaggregates for boosting theranostic efficacy10.1021/acsnano.2c10661 ↗
25. De novo design of reversibly pH-switchable NIR-II aggregation-induced emission luminogens for efficient phototheranostics of patient-derived tumor xenografts10.1021/jacs.2c10076 ↗
26. Precise examination of peripheral vascular disease for diabetics with a novel multiplexed NIR-II fluorescence imaging Technology10.1016/j.nantod.2022.101378 ↗
27. Surface plasmon-enhanced NIR-II fluorescence in a multilayer nanoprobe for through-skull mouse brain imaging10.1021/acsami.2c11218 ↗
28. Tumor-microenvironment-Activated NIR-II nanotheranostic platform for precise diagnosis and treatment of colon cancer10.1021/acsami.2c04242 ↗
29. Rational design of conjugated photosensitizers with controllable photoconversion for dually cooperative phototherapy10.1002/adma.201801216 ↗
30. Asymmetric small organic molecule-based NIR-II fluorophores for high performance tumor phototheranostics10.1039/D1QM00472G ↗
31. Photoactive oligomer with an acceptor–donor–acceptor-conjugated structure for single near-infrared light-triggered photothermal/photodynamic synergistic therapy of tumors10.1021/acsapm.2c02016 ↗
32. Polymer dots for precision photothermal therapy of brain tumors in the second near-infrared window: a mini-review10.1021/acsapm.0c00715 ↗
33. Unadulterated organic nanoparticles with small sizes for robust tumor imaging and photothermal treatment10.1002/adfm.202103714 ↗
34. State-of-the-art self-luminescence: a win–win situation10.1039/D2CS00228K ↗
35. Supramolecular J-aggregates of aza-BODIPY by steric and π–π nteractions for NIR-II phototheranostics10.1039/D1TB02820K ↗
36. Self-assembled porphyrin polymer nanoparticles with NIR-II emission and highly efficient photothermal performance in cancer therapy
37. A hypoxia-activated photothermal agent inhibits multiple heat shock proteins for low-temperature photothermal therapy10.1039/D2CC06598C ↗
38. Coordinating the mechanisms of action of ferroptosis and the photothermal effect for cancer theranostics10.1002/anie.202112925 ↗
39. First demonstration of gold nanorods-mediated photodynamic therapeutic destruction of tumors via near infra-red light activation10.1002/smll.201302719 ↗
40. End group nonplanarization enhances phototherapy efficacy of A–D–A fused-ring photosensitizer for tumor phototherapy10.1021/acs.nanolett.3c00119 ↗
41. Supramolecular agents for combination of photodynamic therapy and other treatments10.1039/D1SC01125A ↗
42. Tongue cancer tailored photosensitizers for NIR-II fluorescence imaging guided precise treatment10.1016/j.nantod.2022.101550 ↗
43. Fabrication of a phototheranostic nanoplatform for single laser-triggered NIR-II fluorescence imaging-guided photothermal/chemo/antiangiogenic combination therapy10.1016/j.actbio.2022.08.013 ↗
44. Photothermally triggered copper payload release for cuproptosis-promoted cancer synergistic therapy